Skip to main content

Table 1 Gene mutations detected by next-generation sequencing at the tissue wax of the patient

From: Molecular and oral manifestations of langerhans cell histiocytosis preceding acute myeloid leukemia

Gene

Amino acid change

Coding

Exon

Variant effect

Allele frequency

Transcript

Locus

Protein change

MIM number

Clinical significance

Phenotype

TET2

p.Q1540*

c.4618C > T

11

Truncated mutation

40.5

NM_001127208.3

612,839

Likely oncogenic

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes, Angioimmunoblastic T-Cell Lymphoma

TET2

p.R131Kfs*5

c.391dup

3

Frameshift mutation

28.6

NM_001127208.3

612,839

Likely oncogenic

BRAF

p.V600E

c.1799 T > A

15

Missense mutation

17.0

NM_004333.6

chr7:140,753,335

V600E

164,757

Oncogenic

Anaplastic Thyroid Cancer, Colorectal Cancer, Melanoma, Non-Small Cell Lung Cancer, Biliary Tract Cancer, Glioma, Astrocytoma, Leukemia

SRSF2

p.P95H

c.284C > A

1

Missense mutation

3.2

NM_001195427.2

600,813

Oncogenic

Acute Myeloid Leukemia

NRAS

p.G12D

c.35G > A

2

Missense mutation

0.8

NM_002524.5

chr1:114,716,126

G12D

164,790

Oncogenic

Colorectal Cancer, Erdheim-Chester Disease, Langerhans Cell Histiocytosis, Rosai-Dorfman Disease, Histiocytosis, Melanoma, Thyroid Cancer

MAP2K4

p.R145W

c.433C > T

5

Missense mutation

3.2

NM_003010.4

601,335

Unknown

MPL

p.W632C

c.1896G > C

12

Missense mutation

5.0

NM_005373.3

159,530

Unknown

Myelofibrosis with myeloid metaplasia, Thrombocythemia 2, Amegakaryocytic Thrombocytopenia

DDX41

p.R311Q

c.932G > A

9

Missense mutation

1.1

NM_016222.4

608,170

Unknown

Myeloproliferative/Lymphoproliferative Neoplasms

MSH3

p.H781Y

c.2341C > T

17

Missense mutation

15.6

NM_002439.5

chr5:80,778,742

H781Y

600,887

Unknown

Endometrial Carcinoma, Familial Adenomatous Polyposis 4